The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
118105286 11810528 6 F 2010 20160809 20151208 20160817 EXP GB-DRREDDYS-GER/UKI/15/0054457 DR REDDYS 72.00 YR F Y 0.00000 20160817 OT GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
118105286 11810528 1 PS AMLODIPINE AMLODIPINE BESYLATE 1 U U UNKNOWN 76692
118105286 11810528 2 SS HERCEPTIN TRASTUZUMAB 1 Subcutaneous U U B00442B01, B1010B08, B104B13,B00442 0 450 MG SOLUTION FOR INJECTION
118105286 11810528 3 SS HERCEPTIN TRASTUZUMAB 1 Subcutaneous U U B00442B01, B1010B08, B104B13,B00442 0 600 MG SOLUTION FOR INJECTION

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
118105286 11810528 1 Product used for unknown indication
118105286 11810528 2 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
118105286 11810528 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
118105286 11810528 Arthralgia
118105286 11810528 Bladder irritation
118105286 11810528 Blood pressure increased
118105286 11810528 Dizziness
118105286 11810528 Dry skin
118105286 11810528 Dysuria
118105286 11810528 Fall
118105286 11810528 Fatigue
118105286 11810528 Feeling abnormal
118105286 11810528 Gingival pain
118105286 11810528 Head injury
118105286 11810528 Hepatic neoplasm
118105286 11810528 Joint swelling
118105286 11810528 Lacrimation increased
118105286 11810528 Local swelling
118105286 11810528 Musculoskeletal stiffness
118105286 11810528 Myalgia
118105286 11810528 Nasal congestion
118105286 11810528 Neoplasm progression
118105286 11810528 Neuralgia
118105286 11810528 Onychoclasis
118105286 11810528 Photophobia
118105286 11810528 Pruritus
118105286 11810528 Rhinorrhoea
118105286 11810528 Sinus pain
118105286 11810528 Skin abrasion
118105286 11810528 Tenderness
118105286 11810528 Trigeminal neuralgia
118105286 11810528 Urinary retention
118105286 11810528 Urine flow decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found